Dupont Capital Management Corp Incyte Corp Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$60.95 - $75.51 $261,902 - $324,466	4,297 Added 77.21%	9,862 $613,000
Q1 2023 Apr 28, 2023	SELL	$70.23 - $86.01 $243,487 - $298,196	-3,467 Reduced 38.39%	5,565 $402,000
Q4 2022 Jan 26, 2023	BUY	$67.18 - $84.11 $414,567 - $519,042	6,171 Added 215.69%	9,032 $0
Q3 2022 Oct 31, 2022	SELL	$66.18 - $82.86 $278,948 - $349,254	-4,215 Reduced 59.57%	2,861 $191,000
Q2 2022 Jul 26, 2022	SELL	$66.18 - $83.18 $268,095 - $336,962	-4,051 Reduced 36.41%	7,076 $538,000
Q1 2022 Apr 27, 2022	BUY	$66.02 - $79.71 $15,448 - $18,652	234 Added 2.15%	11,127 $884,000
Q4 2021 Jan 31, 2022	BUY	$63.34 - $74.11 $341,085 - $399,082	5,385 Added 97.77%	10,893 $800,000
Q3 2021 Nov 03, 2021	SELL	$68.67 - $84.02 $352,345 - $431,106	-5,131 Reduced 48.23%	5,508 $379,000
Q2 2021 Jul 30, 2021	BUY	$79.87 - $87.53 $703,574 - $771,051	8,809 Added 481.37%	10,639 $895,000
Q1 2021 Apr 29, 2021	BUY	$76.02 - $100.5 $139,116 - $183,915	1,830 New	1,830 $149,000
Q4 2020 Jan 28, 2021	SELL	$80.74 - $97.7 $154,536 - $186,997	-1,914 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$85.07 - $109.69 $765,970 - $987,648	-9,004 Reduced 82.47%	1,914 $172,000
Q2 2020 Jul 24, 2020	BUY	$74.18 - $108.93 $13,204 - $19,389	178 Added 1.66%	10,918 $1.14 Million
Q1 2020 Apr 29, 2020	SELL	$63.18 - $85.97 $236,293 - $321,527	-3,740 Reduced 25.83%	10,740 $786,000
Q4 2019 Jan 27, 2020	BUY	$73.04 - $95.72 $465,337 - $609,832	6,371 Added 78.57%	14,480 $1.26 Million
Q3 2019 Oct 28, 2019	BUY	$72.82 - $86.52 $108,793 - $129,260	1,494 Added 22.59%	8,109 $602,000
Q2 2019 Jul 30, 2019	SELL	$73.52 - $88.7 $27,202 - $32,819	-370 Reduced 5.3%	6,615 $562,000
Q1 2019 Apr 30, 2019	BUY	$63.56 - $88.17 $443,966 - $615,867	6,985 New	6,985 $601,000
Q2 2018 Jul 30, 2018	SELL	$60.85 - $83.98 $1.23 Million - $1.7 Million	-20,198 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$83.06 - $100.98 $1.68 Million - $2.04 Million	20,198 New	20,198 $1.68 Million
Q4 2017 Jan 31, 2018	SELL	$93.56 - $116.6 $410,260 - $511,291	-4,385 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$109.15 - $138.27 $478,622 - $606,313	4,385	4,385 $512,000

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account